Position statement of the Spanish Society of Nephrology on the SARS-CoV-2 vaccines()

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide over the last year causing more than one million deaths. Several treatments have tried to modify the natural history of the coronavirus disease 2019 (COVID-19) but only corticosteroids have demonstrated to be effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez-Álvarez, Emilio, Quiroga, Borja, de Sequera, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455244/
https://www.ncbi.nlm.nih.gov/pubmed/34561208
http://dx.doi.org/10.1016/j.nefroe.2021.09.001
Descripción
Sumario:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide over the last year causing more than one million deaths. Several treatments have tried to modify the natural history of the coronavirus disease 2019 (COVID-19) but only corticosteroids have demonstrated to be effective in moderate or severe affectation. In that situation, the development of vaccines for preventing the SARS-CoV-2 infection has focused the attention of the scientific community. At present, available messenger RNA-based technology vaccines have received the approval of local and international sanitary authorities. In this position statement, the Spanish Society of Nephrology wants to state that patients with chronic kidney disease and healthcare workers are at high-risk for contagion and complications of COVID-19 so they must have priority in the vaccine administration.